Literature DB >> 22277982

Impact of donor and recipient race on survival after hepatitis C-related liver transplantation.

Jennifer E Layden1, Scott J Cotler, Shellee A Grim, Michael J Fischer, Michael R Lucey, Nina M Clark.   

Abstract

BACKGROUND: Both donor and recipient race impact outcomes after liver transplantation (LT), especially for hepatitis C virus (HCV). The interaction and simultaneous impact of both on patient survival is not clearly defined. The purpose of this study was to examine the impact of donor and recipient race on recipient and graft survival after HCV-related LT using the United Network for Organ Sharing database.
METHODS: A total of 16,053 recipients (75.5% white, 9.3% black, and 15.2% Hispanic) who underwent primary LT for HCV between 1998 and 2008 were included. Cox regression models were used to assess the association between recipient/donor race and patient survival.
RESULTS: A significant interaction between donor and recipient race was noted (P=0.01). Black recipients with white donors had a higher risk of patient mortality (adjusted hazard ratio, 1.66; 95% confidence interval, 1.47-1.87) compared with that of white recipients with white donors. In contrast, the pairing of Hispanic recipients with black donors was associated with a lower risk of recipient mortality compared with that of white recipients with white donors (adjusted hazard ratio, 0.64; 95% confidence interval, 0.46-0.87). Similar results were noted for graft failure.
CONCLUSION: In conclusion, the impact of donor and recipient race on patient survival varies substantially by the matching of recipient/donor race.

Entities:  

Mesh:

Year:  2012        PMID: 22277982      PMCID: PMC3285232          DOI: 10.1097/TP.0b013e3182406a94

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  34 in total

1.  A model to predict survival at one month, one year, and five years after liver transplantation based on pretransplant clinical characteristics.

Authors:  Paul J Thuluvath; Hwan Y Yoo; Richard E Thompson
Journal:  Liver Transpl       Date:  2003-05       Impact factor: 5.799

2.  The association between hepatitis C infection and survival after orthotopic liver transplantation.

Authors:  Lisa M Forman; James D Lewis; Jesse A Berlin; Harold I Feldman; Michael R Lucey
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

3.  Role of gender and race mismatch and graft failure in patients undergoing liver transplantation.

Authors:  Vinod K Rustgi; Gustavo Marino; Michael T Halpern; Lynt B Johnson; Walter O Umana; Christine Tolleris
Journal:  Liver Transpl       Date:  2002-06       Impact factor: 5.799

4.  Racial and ethnic disparities in access to liver transplantation.

Authors:  Amit K Mathur; Douglas E Schaubel; Qi Gong; Mary K Guidinger; Robert M Merion
Journal:  Liver Transpl       Date:  2010-09       Impact factor: 5.799

5.  HCV-related fibrosis progression following liver transplantation: increase in recent years.

Authors:  M Berenguer; L Ferrell; J Watson; M Prieto; M Kim; M Rayón; J Córdoba; A Herola; N Ascher; J Mir; J Berenguer; T L Wright
Journal:  J Hepatol       Date:  2000-04       Impact factor: 25.083

6.  Hepatitis C infection in African Americans: its natural history and histological progression.

Authors:  Thelma E Wiley; Jennifer Brown; Juliana Chan
Journal:  Am J Gastroenterol       Date:  2002-03       Impact factor: 10.864

Review 7.  Hepatitis C infection in liver transplantation.

Authors:  M Charlton
Journal:  Am J Transplant       Date:  2001-09       Impact factor: 8.086

8.  Viral dynamics and response differences in HCV-infected African American and white patients treated with IFN and ribavirin.

Authors:  Jennifer E Layden-Almer; Ruy M Ribeiro; Thelma Wiley; Alan S Perelson; Thomas J Layden
Journal:  Hepatology       Date:  2003-06       Impact factor: 17.425

9.  Natural history of recurrent hepatitis C.

Authors:  Marina Berenguer
Journal:  Liver Transpl       Date:  2002-10       Impact factor: 5.799

Review 10.  Liver biopsy, viral kinetics, and the impact of viremia on severity of hepatitis C virus recurrence.

Authors:  Michael Charlton
Journal:  Liver Transpl       Date:  2003-11       Impact factor: 5.799

View more
  8 in total

Review 1.  Recurrent hepatitis C after liver transplant.

Authors:  Andrew S deLemos; Paul A Schmeltzer; Mark W Russo
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Racial differences in fibrosis progression after HCV-related liver transplantation.

Authors:  Jennifer E Layden; Scott Cotler; Kimberly A Brown; Michael R Lucey; Helen S Te; Sheila Eswaran; Claus Fimmel; Thomas J Layden; Nina M Clark
Journal:  Transplantation       Date:  2012-07-27       Impact factor: 4.939

3.  Recipient survival and graft survival are not diminished by simultaneous liver-kidney transplantation: an analysis of the united network for organ sharing database.

Authors:  Eric F Martin; Jonathan Huang; Qun Xiang; John P Klein; Jasmohan Bajaj; Kia Saeian
Journal:  Liver Transpl       Date:  2012-08       Impact factor: 5.799

4.  Association of genetic variants with rapid fibrosis: progression after liver transplantation for hepatitis C.

Authors:  Jennifer E Layden; Bamidele O Tayo; Scott J Cotler; Nina M Clark; Kristine Baraoidan; Scott L Friedman; Richard S Cooper
Journal:  Transplantation       Date:  2014-05-27       Impact factor: 4.939

5.  Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation.

Authors:  Scott W Biggins; James Trotter; Jane Gralla; James R Burton; Kiran M Bambha; Jennifer Dodge; Megan Brocato; Linling Cheng; Matt McQueen; Lisa Forman; Michael Chang; Igal Kam; Gregory Everson; Richard A Spritz; Goran Klintmalm; Hugo R Rosen
Journal:  J Hepatol       Date:  2013-01-15       Impact factor: 25.083

6.  Access to Liver Transplantation and Patient Survival among Asian Populations: Pre-Share 35 vs Post-Share 35.

Authors:  Y Zhang
Journal:  Int J Organ Transplant Med       Date:  2017-11-01

7.  The Impact of the Share 35 Policy on Racial and Ethnic Disparities in Access to Liver Transplantation for Patients with End Stage Liver Disease in the United States: An Analysis from UNOS Database.

Authors:  Yefei Zhang
Journal:  Int J Equity Health       Date:  2017-03-24

8.  Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.

Authors:  Yinjie Gao; Hui Ren; Fanping Meng; Jin Li; Eddie Cheung; Hanwei Li; Jingmin Zhao; Hongling Liu; Zhenwen Liu; Min Zhang
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.